카테터 집락화가 없는 지속성 캔디다혈증의 위험인자와 예후
Risk Factors and Prognosis for Persistent Candidemia without Catheter Colonization
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Candidemia is one of the most common causes of nosocomial bloodstream infection, and increases the morbidity and mortality rate of seriously ill patients. We evaluated the risk factors and outcomes associated with persistent candidemia without catheter colonization (non-catheter related candidemia) and compared them with those of non-persistent candidemia. Materials and Methods: A retrospective case-control study was performed to identify risk factors for, and outcomes of, persistent candidemia. All adults who experienced candidemia in a university-affiliated hospital in Korea between January 2005 and December 2009 were included. Patients with catheter colonization were excluded. Persistent candidemia was defined as the occurrence of candidemia in a patient receiving at least 3 days of systemic antifungal agents prior to the second positive blood culture. Results: Of 605 adult patients with candidemia, 104 (17.2%) patients had persistent candidemia and 23 (3.8%) patients were free of catheter colonization. There were no statistically significant differences in baseline characteristics between patients with persistent and non-persistent candidemia. In univariate analysis, less use of metronidazole, glycopeptide, fluoroquinolone, and aminoglycoside, and presence of Candida parapsilosis were significantly associated with persistent candidemia. In multivariate analysis, less use of metronidazole was an independent factor associated with persistent candidemia. The candidemia related mortality was insignificantly (P =0.094) higher in persistent candidemia than non-persistent candidemia. Conclusions: Persistent candidemia can occur without catheterization. Patterns of antibiotic use could be associated with the occurrence of persistent candidemia,and prognosis of persistent candidemia seems to be worse than non-persistent candidemia. Further studies for persistent candidemia should be performed.
Abstract
Background: Candidemia is one of the most common causes of nosocomial bloodstream infection, and increases the morbidity and mortality rate of seriously ill patients. We evaluated the risk factors and outcomes associated with persistent candidemia without catheter colonization (non-catheter related candidemia) and compared them with those of non-persistent candidemia. Materials and Methods: A retrospective case-control study was performed to identify risk factors for, and outcomes of, persistent candidemia. All adults who experienced candidemia in a university-affiliated hospital in Korea between January 2005 and December 2009 were included. Patients with catheter colonization were excluded. Persistent candidemia was defined as the occurrence of candidemia in a patient receiving at least 3 days of systemic antifungal agents prior to the second positive blood culture. Results: Of 605 adult patients with candidemia, 104 (17.2%) patients had persistent candidemia and 23 (3.8%) patients were free of catheter colonization. There were no statistically significant differences in baseline characteristics between patients with persistent and non-persistent candidemia. In univariate analysis, less use of metronidazole, glycopeptide, fluoroquinolone, and aminoglycoside, and presence of Candida parapsilosis were significantly associated with persistent candidemia. In multivariate analysis, less use of metronidazole was an independent factor associated with persistent candidemia. The candidemia related mortality was insignificantly (P =0.094) higher in persistent candidemia than non-persistent candidemia. Conclusions: Persistent candidemia can occur without catheterization. Patterns of antibiotic use could be associated with the occurrence of persistent candidemia,and prognosis of persistent candidemia seems to be worse than non-persistent candidemia. Further studies for persistent candidemia should be performed.
참고문헌 (15)
- Hidron AI, "NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007", Infect Control Hosp Epidemiol, 29, pp.996~1011 (2008)
- 김의종, "전국병원감염감시체계 중환자실 부문 결과 보고: 2008년 7월부터 2009년 6월까지 1년간의 결과와 3년간 전국 중환자실 병원감염발생률의 분석", 병원감염관리, 15(1), pp.14~25 (2010), 대한병원감염관리학회
- Pfaller MA, "Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in communityonset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009", Antimicrob Agents Chemother, 55, pp.561~566 (2011)
- Pfaller MA, "Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)", J Clin Microbiol, 49, pp.396~399 (2011)
- Uzun O, "Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia", Clin Infect Dis, 32, pp.1713~1717 (2001)
- Chung JW, "Risk factors and outcome for breakthrough candidaemia in patients with cancer", Mycoses, 49, pp.114~118 (2006)
- Kontoyiannis DP, "Risk Factors for Candida tropicalis fungemia in patients with cancer", Clin Infect Dis, 33, pp.1676~1681 (2001)
- Pasqualotto AC, "Risk factors and outcome for nosocomial breakthrough candidaemia", J Infect, 52, pp.216~222 (2006)
- Nucci M, "Risk factors for breakthrough candidemia", Eur J Clin Microbiol Infect Dis, 21, pp.209~211 (2002)
- Lee I, "Risk factors for fluconazole-resistant Candida glabrata bloodstream infections", Arch Intern Med, 169, pp.379~383 (2009)
- Lin MY, "Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study", Antimicrob Agents Chemother, 49, pp.4555~4560 (2005)
- Cury AE, "Interactions between amphotericin B and nitroimidazoles against Candida albicans", Mycoses, 40, pp.187~192 (1997)
- Chang MR, "Amphotericin B-metronidazole combination against Candida spp", Rev Iberoam Micol, 15, pp.78~80 (1998)
- Nguyen MH, "Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study", Arch Intern Med, 155, pp.2429~2435 (1995)
- Nucci M, "Risk factors for death in patients with candidemia", Infect Control Hosp Epidemiol, 19, pp.846~850 (1998)